Le Lézard
Classified in: Ebola virus, Health, Covid-19 virus
Subject: PER

Crossroads Treatment Centers Adds Dr. Jerome Adams to Board


Respected physician and former U.S. Surgeon General to help guide treatment initiatives

GREENVILLE, S.C., July 19, 2023 /PRNewswire/ -- Crossroads Treatment Centers (Crossroads) has added Dr. Jerome Adams to its Board of Directors.

Crossroads Treatment Centers (Crossroads) has added Dr. Jerome Adams to its Board of Directors.

Dr. Adams was the 20th U.S. Surgeon General and a prior member of the White House Coronavirus Task Force.  He is currently a Distinguished Professor in the Departments of Pharmacy Practice and Public Health at Purdue University, where he is a Presidential Fellow and the Executive Director of the University's Health Equity Initiatives.

As U.S. Surgeon General, Dr. Adams was the operational head of the 6,000-person U.S. Public Health Service Commissioned Corps.

Dr. Adams is a licensed anesthesiologist with a master's degree in public health. Prior to becoming Surgeon General, he led the Indiana Department of Health. As Indiana State Health Commissioner, he managed a $350 million budget, directed more than 1,000 employees, and led Indiana's response to Ebola, Zika, and the HIV crisis.

Dr. Adams also worked with the Indiana governor and state legislature to legalize syringe service programs in Indiana.  He has partnered with and assisted multiple organizations as they navigate the opioid epidemic, increasing rates of chronic disease, the impacts of rising suicide rates in the U.S., and how businesses can become better stewards in promoting community health.

"Dr. Adams has been a leading, authoritative voice in the medical community, working to address America's most pressing health challenges," says Dr. Rupert McCormac IV, Founder and CEO of Crossroads. "He particularly understands the challenges involved with addressing the health equity gaps in access to quality care and will be invaluable to Crossroads as we continue to help to reduce the barriers to treatment for those with substance use disorder."

About Crossroads Treatment Centers

Since 2005, Crossroads has been at the forefront of treating patients with opioid use disorder. Currently operating more than 110 clinics across 9 states (GA, KY, NJ, NC, PA, SC, TN, TX, and VA), we are a family of doctors, nurse practitioners, counselors, and professionals dedicated to providing the most accessible and highest quality treatment options to combat the growing opioid epidemic.

Contact:         

Crystal Fuller Morley, Vice President of Marketing & Communications


[email protected]


(615) 294-5768

SOURCE Crossroads Treatment Centers


These press releases may also interest you

4 mai 2024
The Better Business Bureau Serving the...

3 mai 2024
CMC Metals Ltd. (CMCXF:OTCQB) ("CMC" or the "Company") announces that as a result of a review by the British Columbia Securities Commission ("BCSC"), the Company is issuing the following news to clarify previous...

3 mai 2024
The Board of Trustees of First Trust Energy Infrastructure Fund (the "Fund") , CUSIP 33738C103, previously approved a managed distribution policy for the Fund (the "Managed Distribution Plan") in reliance on exemptive relief received from the...

3 mai 2024
FGI Industries Ltd. ("FGI" or the "Company"), a leading global supplier of kitchen and bath products, today announced that it will issue financial results for the first quarter 2024 after the market close on Wednesday, May 8, 2024. Management will...

3 mai 2024
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of QuidelOrtho Corporation between February 18, 2022 and April 1, 2024, both dates inclusive (the "Class Period") of the important June 11, 2024 lead...

3 mai 2024
University of Phoenix College of Nursing is pleased to highlight the recent publication by alumna Gloria Littlemouse, Ph.D. in Nursing, MSN, RN, WCSI Scholar, whose dissertation study informed an article, "Lived Experiences of ICU Nurses During...



News published on and distributed by: